Markets:

Overview

News

Currencies

International

Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

449.53 -5.14 (-1.13%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

70 71 Next >

Vertex Pharmaceuticals Just Found Its Newest Blockbuster Drug. A $41 Billion Market Awaits ↗

October 24, 2024

Its latest report of clinical data suggests it has a winner on its hands.

Via The Motley Fool

Looking Into Vertex Pharmaceuticals's Recent Short Interest ↗

October 21, 2024

Via Benzinga

Why We Buy Stocks ↗

October 21, 2024

Is fear of missing out (FOMO) controlling your portfolio?

Via The Motley Fool

Prediction: These 2 Stocks Will Beat the S&P 500 Through 2030 ↗

October 19, 2024

There's no need to change a winning formula.

Via The Motley Fool

Topics Stocks

Market Whales and Their Recent Bets on VRTX Options ↗

October 18, 2024

Via Benzinga

Vertex to Present Phase 3 Data Highlighting Suzetrigine’s Potential as a First-in-Class, Highly Selective Pain Signal Inhibitor at the American Society of Anesthesiologists Annual Meeting

October 18, 2024

From Vertex Pharmaceuticals Incorporated

Via Business Wire

What Analysts Are Saying About Vertex Pharmaceuticals Stock ↗

October 01, 2024

Via Benzinga

Vertex Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (19 Ratings) ↗

October 17, 2024

Via Benzinga

Here's How Much $1000 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth Today ↗

October 16, 2024

Via Benzinga

Got $1,000? 2 Magnificent Growth Stocks to Buy and Hold Forever ↗

October 13, 2024

These profitable companies are facing long-term growth runways.

Via The Motley Fool

3 No-Brainer Growth Stocks to Buy in October ↗

October 13, 2024

These stocks look like slam-dunk picks for growth investors.

Via The Motley Fool

Vertex to Announce Third Quarter 2024 Financial Results on November 4th

October 10, 2024

From Vertex Pharmaceuticals Incorporated

Via Business Wire

If You Invested $100 In This Stock 15 Years Ago, You Would Have $1,200 Today ↗

September 25, 2024

Via Benzinga

Demystifying Vertex Pharmaceuticals: Insights From 16 Analyst Reviews ↗

September 19, 2024

Via Benzinga

Looking Into Vertex Pharmaceuticals's Recent Short Interest ↗

September 18, 2024

Via Benzinga

Biden Administration Unveils Plan To Provide Generic Drugs for $2 to Medicare Recipients ↗

October 09, 2024

The Biden administration's proposed Medicare $2 Drug List Model aims to provide low-cost generic drugs for seniors and people with disabilities, with copayments capped at $2 per month for essential...

Via Benzinga

2 Biotech Stocks to Buy Hand Over Fist in October ↗

October 09, 2024

These longtime leading biotech stocks still have plenty of upside ahead.

Via The Motley Fool

Cathie Wood's Ark Invest Trades: Bets $14M On Amazon Shares — Dumps Robinhood Stock Worth $36M, Embraces Coinbase And Meta ↗

October 08, 2024

Cathie Wood's Ark Invest made significant trades in Amazon.com Inc (NASDAQ: AMZN), Robinhood Markets Inc (NASDAQ: HOOD), and Coinbase Global Inc (NASDAQ: COIN) on Tuesday Oct 8, 2024.

Via Benzinga

S&P 500 Could Reach 6,300 In 12 Months, Says Goldman Sachs, Driven By 'Strong AI Demand' And 'Margin Expansion' ↗

October 07, 2024

Goldman Sachs raises S&P 500's EPS forecast to $268 in 2025, driven by AI tech demand & semiconductor recovery. Margin expansion & macro growth fuel optimism for tech & healthcare sectors.

Via Benzinga

Topics Artificial Intelligence Stocks

Insider Trades: How To Find The Top Stocks ↗

October 04, 2024

There are dozens of insider trades going on every week. Here are 5 insider stock buys that stand out.

Via Talk Markets

3 Top Stocks That Could Still Rocket Higher in 2024 ↗

October 04, 2024

Upcoming Food and Drug Administration decisions could push these stocks through the roof.

Via The Motley Fool

2 Superior Growth Stocks That Are Screaming Buys Right Now ↗

October 04, 2024

These companies have plenty of growth runway left.

Via The Motley Fool

Pfizer Tanked A $5.4 Billion Takeover. Why Crispr, Agios, Beam Could Benefit. ↗

September 26, 2024

Pfizer stock dipped Thursday after the company voluntarily pulled its sickle cell drug, Oxbryta, from the market following patient deaths.

Via Investor's Business Daily

Vertex Highlights First Oral Presentation of Phase 3 Clinical Data of the Vanza Triple and New Data on Long-Term Impact of TRIKAFTA® at the North American Cystic Fibrosis Conference

September 26, 2024

From Vertex Pharmaceuticals Incorporated

Via Business Wire

The Best Biotech Stock to Invest $1,000 in Right Now ↗

September 22, 2024

Vertex Pharmaceuticals isn't an ordinary biotech stock.

Via The Motley Fool

Bull Market and Beyond: 2 Stocks Just Waiting to Soar ↗

September 21, 2024

Great companies have persisted even in a tumultuous market.

Via The Motley Fool

Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030 ↗

September 18, 2024

These biotech stocks have what it takes to be the biggest winners through the rest of the decade and beyond.

Via The Motley Fool

3 Stocks to Buy and Hold Forever ↗

September 14, 2024

These stocks are built for the long run.

Via The Motley Fool

Prediction: These 3 Phenomenal Stocks Are Set to Soar ↗

September 14, 2024

These stocks are already solid winners in 2024. They should be able to keep the momentum going.

Via The Motley Fool

Time To Invest And Or Trade In Bio-Tech Stocks? ↗

September 13, 2024

Biotechnology stocks and biotech exchange-traded funds ETFs once played a significant role in growth equity rallies, but today it seems like those days are in the past. Will an interest rate cut help...

Via Talk Markets

Topics ETFs

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

70 71 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.